Recent advances in targeted therapy of pulmonary fungal infections with a focus on inhaled opelconazole (PC945): a systematic review.

Ahmadvand N, Mohammad Taghi Fam H, Haghani I, Rahmanian N, Dodangeh Balakhani M

Open source

DOI
10.22034/cmm.2026.345519.1746
Published
2026
Container
Current medical mycology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.22034/cmm.2026.345519.1746,
  title = {Recent advances in targeted therapy of pulmonary fungal infections with a focus on inhaled opelconazole (PC945): a systematic review.},
  author = {Ahmadvand N and Mohammad Taghi Fam H and Haghani I and Rahmanian N and Dodangeh Balakhani M},
  year = {2026},
  journal = {Current medical mycology},
  doi = {10.22034/cmm.2026.345519.1746},
  url = {https://doi.org/10.22034/cmm.2026.345519.1746}
}

RIS

TY  - JOUR
TI  - Recent advances in targeted therapy of pulmonary fungal infections with a focus on inhaled opelconazole (PC945): a systematic review.
AU  - Ahmadvand N
AU  - Mohammad Taghi Fam H
AU  - Haghani I
AU  - Rahmanian N
AU  - Dodangeh Balakhani M
PY  - 2026
JO  - Current medical mycology
DO  - 10.22034/cmm.2026.345519.1746
UR  - https://doi.org/10.22034/cmm.2026.345519.1746
ER  - 

APA

N, A., H, M. T. F., I, H., N, R., & M, D. B. (2026). Recent advances in targeted therapy of pulmonary fungal infections with a focus on inhaled opelconazole (PC945): a systematic review.. Current medical mycology. https://doi.org/10.22034/cmm.2026.345519.1746

Source records